How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

A dependency confusion campaign leveraged 33 malicious npm packages to collect reconnaissance data from developer and build environments. This report details the attack chain, observed tradecraft, and ...

Carol M. Kopp edits features on a wide range of subjects for Investopedia, including investing, personal finance, retirement planning, taxes, business management, and career development. Goodboy ...

Unlike compound bows, spotting scope manufacturers don’t release a new flagship model each year. In fact, many optic companies will go years between developing a new spotter. That’s why, as hunters, ...